| Primary |
| Hypertension |
30.2% |
| Drug Use For Unknown Indication |
28.6% |
| Product Used For Unknown Indication |
19.0% |
| Essential Hypertension |
6.3% |
| Anxiety |
3.2% |
| Glaucoma |
3.2% |
| Hypertensive Cardiomyopathy |
3.2% |
| Arthralgia |
1.6% |
| Cor Pulmonale Chronic |
1.6% |
| Secondary Hypertension |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
|
| Hyponatraemia |
8.3% |
| Orthostatic Hypotension |
8.3% |
| Rash Morbilliform |
8.3% |
| Renal Failure Acute |
8.3% |
| Angioneurotic Oedema |
4.2% |
| Cardiac Failure |
4.2% |
| Fall |
4.2% |
| Jaundice |
4.2% |
| Leukocytosis |
4.2% |
| Malaise |
4.2% |
| Oropharyngeal Pain |
4.2% |
| Paraesthesia |
4.2% |
| Pathological Fracture |
4.2% |
| Rectal Haemorrhage |
4.2% |
| Renal Tubular Necrosis |
4.2% |
| Rhabdomyolysis |
4.2% |
| Tachycardia |
4.2% |
| Torsade De Pointes |
4.2% |
| Transaminases Increased |
4.2% |
| Urinary Retention |
4.2% |
|
| Secondary |
| Hypertension |
26.4% |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
21.6% |
| Type 2 Diabetes Mellitus |
4.8% |
| Diabetes Mellitus |
3.8% |
| Essential Hypertension |
2.5% |
| Dyslipidaemia |
2.0% |
| Benign Prostatic Hyperplasia |
1.5% |
| Bronchitis |
1.5% |
| Hypertension Arterial |
1.5% |
| Anxiety |
1.3% |
| Hiv Infection |
1.3% |
| Arrhythmia |
1.0% |
| Glaucoma |
1.0% |
| Ischaemic Cardiomyopathy |
1.0% |
| Depression |
0.8% |
| Dyspepsia |
0.8% |
| Helicobacter Infection |
0.8% |
| Hypothyroidism |
0.8% |
| Parachute Mitral Valve |
0.8% |
|
| Renal Failure Acute |
14.5% |
| Rhabdomyolysis |
12.0% |
| Hyponatraemia |
8.4% |
| Toxic Skin Eruption |
7.2% |
| Vomiting |
7.2% |
| Malaise |
4.8% |
| Thrombocytopenia |
4.8% |
| Weight Decreased |
4.8% |
| Face Oedema |
3.6% |
| Hepatitis Cholestatic |
3.6% |
| Jaundice Cholestatic |
3.6% |
| Rash Maculo-papular |
3.6% |
| Shock |
3.6% |
| Systemic Lupus Erythematosus |
3.6% |
| Agranulocytosis |
2.4% |
| Aortic Valve Disease |
2.4% |
| Insulin-requiring Type 2 Diabetes Mellitus |
2.4% |
| Neutropenia |
2.4% |
| Orthostatic Hypotension |
2.4% |
| Pathological Fracture |
2.4% |
|
| Concomitant |
| Hypertension |
27.3% |
| Drug Use For Unknown Indication |
14.7% |
| Product Used For Unknown Indication |
11.1% |
| Ischaemic Cardiomyopathy |
7.0% |
| Myocardial Ischaemia |
7.0% |
| Rheumatoid Arthritis |
4.5% |
| Diabetes Mellitus |
4.3% |
| Neuralgia |
4.0% |
| Hypercholesterolaemia |
3.2% |
| Hiv Infection |
2.8% |
| Benign Prostatic Hyperplasia |
1.7% |
| Gastritis |
1.7% |
| Essential Hypertension |
1.5% |
| Osteoporosis |
1.5% |
| Depression |
1.4% |
| Oesophageal Neoplasm |
1.4% |
| Prophylaxis |
1.3% |
| Atrial Fibrillation |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Hepatitis B |
1.1% |
|
| Renal Failure |
15.1% |
| Vomiting |
11.8% |
| Renal Failure Acute |
6.7% |
| Rhabdomyolysis |
5.9% |
| Weight Decreased |
5.9% |
| Eosinophilia |
5.0% |
| Pyrexia |
5.0% |
| Hyponatraemia |
4.2% |
| Toxic Skin Eruption |
4.2% |
| Transaminases Increased |
4.2% |
| Drug Interaction |
3.4% |
| Insomnia |
3.4% |
| Lung Disorder |
3.4% |
| Pneumonia |
3.4% |
| Rash Papular |
3.4% |
| Tremor |
3.4% |
| Urticaria |
3.4% |
| Vertigo |
3.4% |
| Gait Disturbance |
2.5% |
| Somnolence |
2.5% |
|
| Interacting |
| Hypertension |
48.0% |
| Arrhythmia |
28.0% |
| Depression |
8.0% |
| Epilepsy |
4.0% |
| Product Used For Unknown Indication |
4.0% |
| Ulcer |
4.0% |
| Vertigo |
4.0% |
|
| Hyponatraemia |
30.0% |
| Drug Interaction |
10.0% |
| Intentional Overdose |
10.0% |
| Loss Of Consciousness |
10.0% |
| Orthostatic Hypotension |
10.0% |
| Pelvic Fracture |
10.0% |
| Renal Failure |
10.0% |
| Traumatic Haematoma |
10.0% |
|
